Cargando…

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7

[Image: see text] Adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) are two peptides with vasodilative, bronchodilative, and angiogenic properties, originating from a common precursor, proADM. Previous studies proposed that the atypical chemokine receptor ACKR3 might act as a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyrath, Max, Palmer, Christie B., Reynders, Nathan, Vanderplasschen, Alain, Ollert, Markus, Bouvier, Michel, Szpakowska, Martyna, Chevigné, Andy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033753/ https://www.ncbi.nlm.nih.gov/pubmed/33860204 http://dx.doi.org/10.1021/acsptsci.1c00006

Ejemplares similares

CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
por: Chevigné, Andy, et al.
Publicado: (2021)

The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7
por: Szpakowska, Martyna, et al.
Publicado: (2021)

The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
por: Meyrath, Max, et al.
Publicado: (2020)

The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B
por: D’Uonnolo, Giulia, et al.
Publicado: (2022)

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
por: Meyrath, Max, et al.
Publicado: (2022)

CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
por: Kouzeli, Ariadni, et al.
Publicado: (2020)

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity
por: Melgrati, Serena, et al.
Publicado: (2023)

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
por: Reynders, Nathan, et al.
Publicado: (2019)

Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
por: Chatterjee, Madhumita
Publicado: (2022)

Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma
por: Isci, Damla, et al.
Publicado: (2021)

New pairings and deorphanization among the atypical chemokine receptor family — physiological and clinical relevance
por: Szpakowska, Martyna, et al.
Publicado: (2023)

ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
por: Matti, Christoph, et al.
Publicado: (2020)

The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer
por: Pacifico, Francesco, et al.
Publicado: (2017)

Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011)

The Duffy Antigen Receptor for Chemokines DARC/ACKR1
por: Horuk, Richard
Publicado: (2015)

Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings
por: Lewandowska, Paulina, et al.
Publicado: (2020)

Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells
por: Sigmund, Elena C., et al.
Publicado: (2023)

ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017)

Corrigendum: ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017)

Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling
por: Wei, Sung-Tai, et al.
Publicado: (2020)

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
por: García-Cuesta, Eva M., et al.
Publicado: (2019)

Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein Substrates
por: Jacquet, Alain, et al.
Publicado: (2017)

The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury
por: Woodcock, Thomas M., et al.
Publicado: (2017)

Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2
por: Vacchini, Alessandro, et al.
Publicado: (2020)

Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)
por: Bonnavion, Remy, et al.
Publicado: (2023)

Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
por: Duval, Vincent, et al.
Publicado: (2022)

Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
por: Pawnikar, Shristi, et al.
Publicado: (2022)

Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells
por: Neves, Maria, et al.
Publicado: (2022)

The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma
por: Neirinckx, Virginie, et al.
Publicado: (2019)

DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists
por: Naqvi, Ibtehaj, et al.
Publicado: (2022)

The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens
por: Hansell, Chris AH, et al.
Publicado: (2015)

The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density
por: Lee, Kit M, et al.
Publicado: (2014)

Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland
por: Wilson, Gillian J., et al.
Publicado: (2017)

Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2
por: Shams, Kave, et al.
Publicado: (2017)

Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12
por: del Molino del Barrio, Irene, et al.
Publicado: (2018)

The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis
por: Luker, Kathryn E., et al.
Publicado: (2022)

Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
por: Van Loy, Tom, et al.
Publicado: (2022)

Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer’s disease risk
por: Murcia, Josue D. Gonzalez, et al.
Publicado: (2020)

Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice
por: Zheng, Shirong, et al.
Publicado: (2016)

The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
por: Hansell, Christopher A. H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_htp88h3617ohr0n94p04vnm8go